Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» LN-145
LN-145
Iovance receives more good news as FDA lifts hold on lung cancer cell therapy trial
Fierce Biotech
Mon, 03/4/24 - 11:50 am
Iovance Biotherapeutics
FDA
LN-145
lung cancer
cell therapy
clinical trials
Iovance (IOVA) Announces Lung Cancer Study Data on TIL Therapy
Yahoo/Zacks.com
Wed, 06/30/21 - 10:52 am
Iovance
LN-145
metastatic non-small cell lung cancer
Emboldened by ASCO data, FDA etches speedy approval path for Iovance's cervical cancer therapy
Endpoints
Tue, 07/2/19 - 10:20 am
FDA
cervical cancer
Iovance
LN-145
3 Biotech Stocks That Soared Last Week
Motley Fool
Sun, 05/19/19 - 04:02 pm
Adverum Biotechnologies
ADVM-022
Iovance
LN-145
cervical cancer
MeiraGTx
AAV-RPE65
May 15 ASCO Quick Takes: After-hours pop for Iovance, MacroGenics; plus Takeda, Amgen, Forty Seven
BioCentury
Wed, 05/15/19 - 11:52 pm
Iovance
LN-145
cervical cancer
Takeda
TAK-788
non-small cell lung cancer
Amgen
AMG-510
Macrogenics
margetuximab
HER2-positive metastatic breast cancer
Forty Seven